Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Ondansetron for PONV in Elderly Women
NCT02541019Phase 4Completed
- Sponsor
- Hospital Federal de Bonsucesso
- Start
- Oct 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of palonosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Hospital Federal de Bonsucesso. Primary endpoint: Frequency and intensity of individual episodes of PONV at 48 hours. Started Oct 2015; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02541019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541019.